1Celli BR, MacNee W, ATS/ERS Task Force.Standards for the diagnosis and treatment of patients with COPD: a summary of the ATS/ERS position paper.Eur Respir J,2004,23:932-946.
2Hamid Q, Song Y, Kotsimbos TC, et al. Inflammation of small airways in asthma. J Allergy Clin Immunol, 1997,100:44-51.
3Joo JH, Park SJ, Park SW, et al. Clinical features of eosinophilic bronchitis. Korean J Intern Med,2002,17:31-37.
4Gibson PG, Fujimura M, Niimi A. Eosinophilic bronchitis: clinical manifestations and implications for treatment. Thorax,2002, 57:178-182.
5Jayaram L, Parameswaran K, Sears MR, et al. Induced sputum cell counts: their usefulness in clinical practice. Eur Respir J, 2000, 16: 150-158.
6Alexis NE, Hu SC, Zeman K, et al. Induced sputum derives from the central airways: confirmation using a radiolabeled aerosol bolus delivery technique. Am J Respir Crit Care Med, 2001, 164:1964-1970.
7Ohno I, Nitta Y, Yamauchi K, et al. Transforming growth factor beta 1 (TGF beta 1) gene expression by eosinophils in asthmatic airway inflammation. Am J Respir Cell Mol Biol,1996,15:404-409.
8Ohno I, Lea RG, Flanders KC, et al. Eosinophils in chronically inflamed human upper airway tissues express transforming growth factor beta 1 gene (TGF beta 1). J Clin Invest,1992,89:1662-1668.
9Owen WF Jr, Soberman RJ, Yoshimoto T, et al. Synthesis and release of leukotriene C4 by human eosinophils. J Immunol,1987, 138:532-538.
10Laitinen LA, Laitinen A, Haahtela T, et al. Leukotriene E4 and granulocytic infiltration into asthmatic airways. Lancet, 1993,341:989-990.
